Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
about
Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interfaceResistance to HIV InfectionTransfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infectionMouse models with human immunity and their application in biomedical research.Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.A human lung xenograft mouse model of Nipah virus infection.HIV-1: maternal prognosis.Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.Can an immune-regulatory vaccine prevent HIV infection?IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells.Host factors in the pathogenesis of HIV disease.Induction of interleukin-10 by HIV antigens in peripheral mononuclear cells of health care workers after occupational exposure to HIV-1-positive blood.Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques.Expression and immunological characterization of cardamom mosaic virus coat protein displaying HIV gp41 epitopes.
P2860
Q21245044-124876F7-D7CD-4B81-98C9-2A2510D01547Q27473466-C8B3D193-A422-4F85-93F5-41A15A334C53Q33825360-5FEE354D-99ED-4D64-9C86-978D9122858AQ34590684-D0D92C77-05F0-4E6D-BCD1-D1E9320EA64BQ35137965-4C7DDDFD-96C6-4F3F-9575-5E2EC3624A97Q35139237-55D423EF-8F34-4FB0-9BEE-76808C48D3D4Q35695524-7F1E94AE-E047-434D-A0C9-7467A9358E0FQ35845894-5166D9DB-5D59-425F-AF25-2B8225357136Q35868629-BB41D666-DB21-4A2A-A58F-BB90D95C74FAQ37271034-B4ACE970-DA79-47E7-88FB-984A012E8E50Q38310502-8EEAAE98-30B6-4504-9DD2-01B9CD4A1F0EQ38949921-11D6BEAB-E31C-47F2-893E-CA1A94F51EEAQ39604525-F69F38AC-77FD-4FE8-B9D0-56C7ED0D6230Q44448809-DADC6640-3C2C-42EF-ACE3-3D2F78D392E0Q45351263-B13E3ACF-1AA7-44EA-B138-127BC0493A5B
P2860
Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@en
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@nl
type
label
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@en
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@nl
prefLabel
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@en
Inhibition of acute in vivo hu ...... human fetal thymus and liver.
@nl
P2093
P2860
P356
P1476
Inhibition of acute in vivo hu ...... h human fetal thymus and liver
@en
P2093
A Rubinstein
H Goldstein
M Hachamovitch
M Pettoello-Mantovani
N F Katopodis
P2860
P304
P356
10.1073/PNAS.93.7.3126
P407
P577
1996-04-01T00:00:00Z